VCP Scanner
ScreenerTechnicalBreakoutsThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistPricing
ScreenerTechnical ScannerBreakoutsThemes
Earnings
WatchlistPricing
Ctrl K
FMS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
FMSFresenius Medical Care AG & Co. KGaA
$23.50$12.6B
Overview & Verdict
OverviewVisualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksFMSBalance Sheet

Fresenius Medical Care AG & Co. KGaA (FMS) Balance Sheet

28Y historyFree accessUpdated daily

Leverage has crept up to a D/E of 0.81 as equity fell to $12.6B, with goodwill of $14.0B (45% of assets) posing an impairment overhang.

FMS Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98
Total Current Assets7.69B7.9B7.92B8.7B8.2B7.97B7.28B7.17B7.85B6.37B6.88B6.19B5.52B4.55B4.63B4.39B3.87B3.3B3.03B2.65B2.59B2.08B1.8B1.75B1.74B2B1.68B1.53B1.21B
Cash & Short-Term Investments1.45B1.6B1.34B1.56B1.46B1.64B1.26B1.16B2.27B993.57M974.72M770.42M678.57M530.94M520.25M352.82M393.15M210.24M159.17M167.83M120.48M71.83M43.5M38.45M61.75M69.2M68.76M34.54M27.2M
Cash Only1.06B1.6B1.18B1.4B1.27B1.48B1.08B1.01B2.15B978.11M708.88M505.95M523.66M495.8M520.25M352.82M393.15M210.24M159.17M167.83M120.48M71.83M43.5M38.45M61.75M69.2M68.76M34.54M27.2M
Short-Term Investments388.1M0163.09M154.37M187.83M159.18M179.26M155.55M119.51M15.46M265.84M264.47M154.91M35.14M000000000000000
Accounts Receivable3.47B3.14B3.41B3.64B3.72B3.58B3.26B3.59B3.43B3.5B3.7B3.33B2.92B2.41B2.67B2.56B2.02B1.79B1.69B1.46B1.51B1.27B1.12B1.02B910.69M1.04B857.09M766.04M544.17M
Days Sales Outstanding63.8758.4364.3568.2669.9974.1766.775.0275.6771.8579.3179.3181.8683.1993.4994.5281.3783.0480.8979.8585.5581.0688.7784.5268.6169.2469.9373.2666.45
Inventory2.33B2.14B2.07B2.18B2.3B2.04B1.9B1.66B1.47B1.29B1.34B1.23B921.61M796.66M783.97M746.47M608.36M573.48M507.9M436.37M396.98M363.81M326.73M353.14M354.72M389.31M340.97M299.43M253.58M
Days Inventory Outstanding56.5253.5351.7754.7557.7857.9156.1450.254739.9942.3243.1937.7540.6841.1442.6837.3440.4436.9536.4934.0235.4339.0343.8939.6339.2642.7451.3856.34
Other Current Assets442.88M1.02B1.06B1.28B682.6M672.58M817.6M700.46M603.63M516.11M800.16M832.98M968.72M781.73M560.76M618.03M263.29M221.13M232.83M244.46M222.06M151.61M136.75M142.64M180.95M255.37M188.56M431.62M389.32M
Total Non-Current Assets23.6B23.1B25.64B25.23B27.55B26.4B24.41B25.77B18.4B17.65B18.62B17.01B15.35B12.19B12.25B10.68B8.98B7.74B7.69B7.07B7.3B4.66B4.07B4.21B4.73B5.32B4.68B4.19B3.63B
Property, Plant & Equipment6.43B3.01B7.26B7.45B8.34B8.55B8.19B8.52B3.84B3.49B3.58B3.15B2.72B2.25B2.22B2.03B1.9B1.69B1.61B1.41B1.31B1.03B871.88M864.81M874.7M942.49M786.83M638.13M538.45M
Fixed Asset Turnover3.49x6.51x2.66x2.61x2.33x2.06x2.18x2.05x4.31x5.09x4.76x4.85x4.79x4.71x4.69x4.87x4.77x4.65x4.75x4.73x4.93x5.57x5.27x5.08x5.54x5.79x5.69x5.98x5.55x
Goodwill13.97B015.17B14.65B15.79B14.36B12.96B14.02B12.21B12.1B12.99B11.92B10.76B8.44B8.64B7.09B6.12B5.24B5.25B4.97B5.22B00000000
Intangible Assets1.28B14.83B1.37B1.36B1.52B1.46B1.38B1.43B681.33M683.06M805.55M759.62M714.97M548.84M536.95M529.79M520.72M599.68M608.07M473.22M501.11M3.41B2.99B3.07B3.57B4.14B3.7B3.42B2.97B
Long-Term Investments3.44B01.12B1.08B1.2B786.9M761.11M696.87M649.78M647.01M598.15M593.62M559.16M482.49M481.94M533.93M188.26M4.04M00000000000
Other Non-Current Assets296.47M5.26B720.02M681.83M702.46M1.24B1.13B1.11B1.02B725.15M683.12M610.72M614.8M479.79M302.01M427.94M179.12M162.47M159.75M163.13M222.86M192.66M168.43M239.84M249.36M203.52M166.41M129.49M119.3M
Total Assets31.29B31B33.57B33.93B35.75B34.37B31.69B32.93B26.24B24.03B25.5B23.2B20.87B16.74B16.88B15.07B12.85B11.04B10.72B9.72B9.88B6.74B5.87B5.96B6.46B7.32B6.37B5.72B4.84B
Asset Turnover0.62x0.63x0.58x0.57x0.54x0.51x0.56x0.53x0.63x0.74x0.67x0.66x0.62x0.63x0.62x0.66x0.71x0.71x0.71x0.69x0.65x0.85x0.78x0.74x0.75x0.75x0.70x0.67x0.62x
Asset Growth %-16.5%-7.64%-1.07%-5.1%4.04%8.45%-3.78%25.5%9.23%-5.8%9.93%11.15%24.66%-0.82%12.02%17.25%16.4%3.03%10.27%-1.67%46.64%14.76%-1.42%-7.79%-11.77%15.04%11.36%18.05%-
Total Current Liabilities7.18B6.25B5.66B6.11B6.47B7.26B6.06B7.06B6.27B5.3B5.3B3.8B2.86B2.57B2.4B3.29B2.85B1.82B2.26B2.08B1.8B1.33B1.43B1.12B1.23B1.55B1.48B1.76B831.86M
Accounts Payable891.84M738M984.32M885.15M951.58M857.53M827.39M835.19M795.05M737.84M839.63M714.21M587.1M482.68M563.81M503.55M316.28M252.95M262.92M226.28M418.86M261.11M225.73M243.39M177.2M222.86M299.4M280.82M127.47M
Days Payables Outstanding21.3518.4524.6422.2423.9524.3724.5125.2325.4722.8626.5724.9924.0524.6529.5928.7919.4117.8419.1318.9235.8925.4326.9630.2519.822.4837.5348.1928.32
Short-Term Debt1.74B1.61B577.38M944.6M1.34B1.92B1.09B2.62B2.5B1.65B1.3B725M371.26M484.77M345.23M1.32B710.05M338.1M818.62M208.92M375.77M250.03M483.25M166.57M146.15M307.25M616.57M570.3M183.15M
Deferred Revenue (Current)0082.17M85.82M105.72M518.03M606.3M30.94M0275.13M218.13M00000000000000249.3M000
Other Current Liabilities3.73B3.31B2.84B2.99B2.86B2.75B2.42B2.44B2.9B2.48B1.98B765.91M793.54M700.59M642.25M716.96M873.33M22.98M20.58M474.88M100.03M113.2M173.86M162.13M281.8M308.74M147.51M908.08M521.23M
Current Ratio1.07x1.26x1.40x1.42x1.27x1.10x1.20x1.02x1.25x1.20x1.30x1.63x1.93x1.77x1.93x1.34x1.36x1.81x1.34x1.28x1.44x1.56x1.26x1.56x1.41x1.29x1.14x0.87x1.46x
Quick Ratio0.75x0.92x1.03x1.07x0.91x0.82x0.89x0.78x1.02x0.96x1.05x1.31x1.61x1.46x1.61x1.11x1.15x1.50x1.11x1.07x1.22x1.29x1.03x1.25x1.12x1.04x0.91x0.70x1.15x
Cash Conversion Cycle99.0493.5191.48100.77103.83107.7298.34100.0497.1988.9995.0697.5195.5699.22105.04108.4199.3105.6498.7197.4283.6891.06100.8398.1688.4486.0375.1476.4594.47
Total Non-Current Liabilities10.58B10.47B12.14B12.99B13.84B13.13B13.3B12.65B7.07B7.9B9.15B9.8B9.77B7.3B7.52B5.56B4.35B4.48B4.06B3.82B4.34B2.04B1.75B2.25B2.53B2.81B2.01B1.95B1.98B
Long-Term Debt5.82B5.69B6.26B6.96B7.17B6.65B6.8B6.46B5.05B5.79B6.83B7.18B7.41B5.61B5.93B4.24B3.24B3.09B2.84B2.75B2.9B597.01M402.46M882.66M1.04B826.94M700.42M649.72M921.81M
Capital Lease Obligations11.63B2.91B3.5B3.53B4B4.09B3.88B4.07B0000000000006.28M00000000
Deferred Tax Liabilities2.04B0708.89M750.29M936.48M868.45M785.89M739.7M626.52M467.54M661.92M571.21M661.68M538.35M502.08M453.52M381.14M298.4M306.23M259.6M286.78M253.85M208.22M198.86M161.41M160.55M187.91M166.99M162.01M
Other Non-Current Liabilities1.27B1.88B1.63B1.74B1.72B1.53B1.83B1.38B1.4B1.63B1.66B2.05B1.69B1.15B1.09B869.24M725.17M1.09B911.43M813.47M1.15B1.19B1.14B1.17B1.33B1.82B1.12B1.13B900.25M
Total Liabilities17.76B16.72B17.8B19.1B20.3B20.39B19.36B19.71B13.34B13.2B14.45B13.6B12.63B9.87B9.92B8.85B7.2B6.3B6.32B5.9B6.14B3.37B3.18B3.37B3.76B4.36B3.49B3.71B2.82B
Total Debt10.96B10.79B11B12.08B13.21B13.32B12.38B13.82B7.58B7.52B8.13B7.96B7.82B6.12B6.27B5.56B3.95B3.43B3.66B2.96B3.28B847.04M885.71M1.05B1.18B1.13B1.32B1.22B1.1B
Net Debt9.9B9.2B9.82B10.67B11.94B11.84B11.3B12.81B5.43B6.55B7.42B7.46B7.3B5.62B5.75B5.21B3.56B3.22B3.5B2.79B3.16B775.21M842.21M1.01B1.12B1.06B1.25B1.19B1.08B
Debt / Equity0.81x0.76x0.70x0.81x0.86x0.95x1.00x1.04x0.59x0.69x0.74x0.83x0.95x0.89x0.90x0.89x0.70x0.72x0.83x0.77x0.87x0.25x0.33x0.41x0.44x0.38x0.46x0.61x0.55x
Debt / EBITDA3.18x3.24x3.43x3.87x3.94x3.83x3.03x3.58x2.01x2.43x2.53x2.86x3.22x2.91x2.94x2.74x2.16x2.22x2.44x2.22x2.66x0.84x1.11x1.36x1.37x1.44x1.35x1.45x1.69x
Net Debt / EBITDA2.88x2.76x3.06x3.42x3.56x3.41x2.76x3.32x1.44x2.11x2.31x2.68x3.01x2.67x2.70x2.56x1.95x2.08x2.33x2.09x2.56x0.77x1.05x1.31x1.30x1.35x1.28x1.41x1.65x
Interest Coverage4.88x4.93x3.60x3.43x4.39x5.45x5.72x4.75x4.87x5.80x5.79x4.88x4.72x5.13x5.11x5.99x6.38x5.53x4.69x4.03x3.60x--------
Total Equity13.53B14.28B15.77B14.83B15.45B13.98B12.33B13.23B12.9B10.83B11.05B9.6B8.25B6.87B6.96B6.22B5.66B4.75B4.4B3.82B3.75B3.37B2.69B2.59B2.7B2.96B2.87B2.01B2.03B
Equity Growth %-29.32%-9.42%6.35%-4.03%10.52%13.36%-6.77%2.52%19.15%-2.02%15.11%16.41%20.06%-1.34%11.94%9.94%19.22%7.88%15.02%2.05%11.28%24.96%4.17%-4.07%-9.01%3.09%42.92%-0.75%-
Book Value per Share25.0924.5326.8725.2713.1711.9313.9014.9121.0017.6218.0415.7213.6111.2811.3410.199.377.957.386.446.335.724.186.166.427.065.334.254.83
Total Shareholders' Equity12.56B14.28B14.58B13.62B13.99B12.7B11.22B11.96B11.76B9.82B9.98B9.04B7.77B6.69B6.76B6.1B5.55B4.66B4.28B3.82B3.69B3.36B2.68B2.58B2.68B2.94B2.85B1.99B2.01B
Common Stock268.56M14.28B293.41M293.41M293.41M293M292.88M304.44M307.88M308.11M360.92M354.12M316.79M276.93M283.49M00145.92M00229.29M193.76M169.29M182.23M218.7M257.93M244.35M228.07M195.43M
Retained Earnings12.09B011.27B10.92B10.71B10.83B10.25B9.45B8.83B7.14B8.4B7.2B5.84B4.62B4.21B3.59B2.9B2.17B1.76B1.29B1.03B823.52M485.32M300.15M147.32M-65.69M-59.65M-215.52M68.3M
Treasury Stock-93.79M000000-370.5M-50.99M-108.93M-50.99M-464.99M-417.22M-366.72M000000000000000
Accumulated OCI-1.31B0-328.55M-975.17M-388.47M-1.31B-2.21B-1.04B-1.2B-1.49B-1.25B-1.22B-894.52M-398.72M-372.11M-374.79M-145.9M-34.71M-108.67M69.19M-4.1M-120.55M-50.85M-138.8M-365.33M-403.57M-205.46M-134.57M-64.8M
Minority Interest974.54M01.19B1.21B1.46B1.28B1.12B1.27B1.14B1.01B616.47M556.9M481.13M181.38M200.19M316.34M110.27M145.71M072.57M56.95M12.16M13.3M11.2M21.46M22.74M22.65M21.64M16.97M

Key Metrics

Growth RegimeStable
ProfitabilityStrained
Balance SheetMixed
Cash FlowStable
Top Statement Risk

Labor cost inflation

Balance Sheet Drift and Deleveraging

Total assets contracted from $34.3B in 2024Q1 to $31.3B in 2026Q2, while debt fell from $12.1B to $11.0B, per reported figures, indicating a gradual deleveraging trend.

The balance sheet has been shrinking over the past two years, with total assets down roughly 9% from the 2024Q1 peak. This contraction appears driven by asset disposals and a reduction in goodwill, which fell from $14.7B to $14.0B, suggesting portfolio pruning. The modest decline in total debt alongside stable equity levels implies a deliberate effort to reduce leverage, though the pace is slow and may reflect limited growth opportunities.

Leverage Creeps Higher Despite Stable Debt

Debt-to-equity rose from 0.70 in 2025Q1 to 0.81 in 2026Q2, per financial statements, as equity eroded by $1.8B while total debt remained near $11B.

The D/E ratio has increased from 0.70 to 0.81 over the last five quarters, not because of additional borrowing but because equity has declined. Retained earnings have been volatile, dropping to zero in 2025Q4 before recovering to $12.1B, suggesting dividend payouts or impairments. The absolute debt level is stable, but the rising leverage ratio indicates a thinner equity cushion, which could amplify sensitivity to interest rate changes.

Goodwill Dominates Asset Base

Goodwill of $14.0B represents 45% of total assets as of 2026Q2, per balance sheet data, while net PPE is only $6.4B, underscoring the acquisition-heavy growth model.

The asset mix is heavily weighted toward intangible assets, with goodwill nearly double the tangible fixed asset base. This suggests that past acquisitions have been the primary driver of scale, but it also exposes the balance sheet to impairment risk if cash flows from those acquisitions underperform. The relatively low PPE relative to revenue indicates an asset-light service model, but the high goodwill raises questions about the quality of capital deployed.

Equity Erosion and Buyback Tension

Total equity fell from $14.6B in 2024Q4 to $12.6B in 2026Q2, per reported figures, while share repurchases totaled $1.06B over the last four quarters, per cash flow statements.

The decline in equity is notable, with a $2B reduction over six quarters, even as the company returned over $1B to shareholders via buybacks. Retained earnings have been inconsistent, dropping to zero in 2025Q4, which may indicate a large dividend or a reclassification. The combination of buybacks and shrinking equity suggests that capital returns are not being fully offset by earnings retention, potentially straining the equity base.

Liquidity Buffer Thins

Current ratio fell from 1.50 in 2024Q1 to 1.07 in 2026Q2, per balance sheet data, while cash declined from $1.1B to $1.1B, indicating a tighter short-term position.

The current ratio has deteriorated steadily, from 1.50 to 1.07, approaching the 1.0 threshold that signals potential liquidity stress. Cash levels have remained flat around $1.1B, but current liabilities have grown relative to current assets, likely due to increased payables or accrued expenses. This trend warrants monitoring, as a ratio below 1.0 could indicate difficulty meeting short-term obligations without external financing.

Goodwill Impairment Overhang

Goodwill of $14.0B, per balance sheet, is nearly 45% of total assets, and any impairment would directly hit equity, which is already under pressure.

The large goodwill balance is the most significant distortion on the balance sheet. Given the company's strained profitability and modest growth, the carrying value of these intangibles may not be fully supported by future cash flows. An impairment charge would reduce equity further and could push the D/E ratio higher, compounding the leverage concerns. Investors should monitor segment performance and any indicators of impairment testing.

FMS — Frequently Asked Questions

Quick answers to the most common questions about buying FMS stock.

What are the total assets of Fresenius Medical Care AG & Co. KGaA (FMS)?

As of 2025, Fresenius Medical Care AG & Co. KGaA (FMS) had total assets of $31.00B including $7.90B in current assets.

How much debt does Fresenius Medical Care AG & Co. KGaA (FMS) have?

Fresenius Medical Care AG & Co. KGaA (FMS) carries total debt of $10.79B, offset by $1.60B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA (FMS) has total shareholders' equity (book value) of $14.28B ($24.53 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Fresenius Medical Care AG & Co. KGaA's current ratio and liquidity?

Fresenius Medical Care AG & Co. KGaA (FMS) reported a current ratio of 1.26x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.